Pathway- and Expression Level-Dependent Effects of Oncogenic N-Ras: p27^Kip1 Mislocalization by the Ral-GEF Pathway and Erk-Mediated Interference with Smad Signaling

REFERENCES

• Alexandrow, M. G., and H. L. Moses. 1995. Transforming growth factor β and cell cycle regulation. Cancer Res. 55:1452–1457.
   PubMed Web of Science ®Google Scholar
• Attisano, L., and J. L. Wrana. 2002. Signal transduction by the TGF-β superfamily. Science 296:1646–1647.
   PubMed Web of Science ®Google Scholar
• Baldassarre, G., B. Belletti, P. Bruni, A. Boccia, F. Trapasso, F. Pentimalli, M. V. Barone, G. Chiappetta, M. T. Vento, S. Spiezia, A. Fusco, and G. Viglietto. 1999. Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells. J. Clin. Investig. 104:865–874.
   PubMed Web of Science ®Google Scholar
• Bar-Sagi, D., and A. Hall. 2000. Ras and Rho GTPases: a family reunion. Cell 103:227–238.
   PubMed Web of Science ®Google Scholar
• Besson, A., M. Gurian-West, A. Schmidt, A. Hall, and J. M. Roberts. 2004. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev. 18:862–876.
   PubMed Web of Science ®Google Scholar
• Boehm, M., T. Yoshimoto, M. F. Crook, S. Nallamshetty, A. True, G. J. Nabel, and E. G. Nabel. 2002. A growth factor-dependent nuclear kinase phosphorylates p27Kip1 and regulates cell cycle progression. EMBO J. 21:3390–3401.
   PubMed Web of Science ®Google Scholar
• Bos, J. L. 1995. p21ras: an oncoprotein functioning in growth factor-induced signal transduction. Eur. J. Cancer 31:1051–1054.
   Google Scholar
• Bos, J. L. 1989. Ras oncogenes in human cancer: a review. Cancer Res. 49:4682–4689.
   PubMed Web of Science ®Google Scholar
• Brattain, M. G., S. D. Markowitz, and J. K. Willson. 1996. The type II transforming growth factor-β receptor as a tumor-suppressor gene. Curr. Opin. Oncol. 8:49–53.
   PubMedGoogle Scholar
• Carrano, A. C., E. Eytan, A. Hershko, and M. Pagano. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193–199.
   PubMed Web of Science ®Google Scholar
• Chen, C. R., Y. Kang, and J. Massague. 2001. Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor β growth arrest program. Proc. Natl. Acad. Sci. USA 98:992–999.
   PubMed Web of Science ®Google Scholar
• Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X. F. Wang. 1995. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92:5545–5549.
   PubMed Web of Science ®Google Scholar
• Derynck, R., R. J. Akhurst, and A. Balmain. 2001. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29:117–129.
   PubMed Web of Science ®Google Scholar
• Downward, J. 2003. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3:11–22.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livingston. 1993. TGF β inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009–1020.
   PubMed Web of Science ®Google Scholar
• Fiordalisi, J. J., R. L. Johnson, II, A. S. Ulku, C. J. Der, and A. D. Cox. 2001. Mammalian expression vectors for Ras family proteins: generation and use of expression constructs to analyze Ras family function. Methods Enzymol. 332:3–36.
   PubMedGoogle Scholar
• Frederick, J. P., N. T. Liberati, D. S. Waddell, Y. Shi, and X. F. Wang. 2004. Transforming growth factor β-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol. Cell. Biol. 24:2546–2559.
   PubMed Web of Science ®Google Scholar
• Fridman, M., H. Maruta, J. Gonez, F. Walker, H. Treutlein, J. Zeng, and A. Burgess. 2000. Point mutants of c-raf-1 RBD with elevated binding to v-Ha-Ras. J. Biol. Chem. 275:30363–30371.
   PubMedGoogle Scholar
• Fujita, N., S. Sato, K. Katayama, and T. Tsuruo. 2002. Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J. Biol. Chem. 277:28706–28713.
   PubMedGoogle Scholar
• Fujita, N., S. Sato, and T. Tsuruo. 2003. Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization. J. Biol. Chem. 278:49254–49260.
   PubMed Web of Science ®Google Scholar
• Gilboa, L., A. Nohe, T. Geissendorfer, W. Sebald, Y. I. Henis, and P. Knaus. 2000. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol. Biol. Cell 11:1023–1035.
   PubMedGoogle Scholar
• Goi, T., G. Rusanescu, T. Urano, and L. A. Feig. 1999. Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth. Mol. Cell. Biol. 19:1731–1741.
   PubMed Web of Science ®Google Scholar
• Grady, W. M., A. Rajput, L. Myeroff, D. F. Liu, K. Kwon, J. Willis, and S. Markowitz. 1998. Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res. 58:3101–3104.
   PubMed Web of Science ®Google Scholar
• Hahn, S. A., M. Schutte, A. T. M. Shamsul Hoque, C. A. Moskaluk, L. T. da Costa, E. Rozenblum, C. L. Weinstein, A. Fischer, C. J. Yeo, R. H. Hruban, and S. E. Kern. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350–353.
   PubMed Web of Science ®Google Scholar
• Hamad, N. M., J. H. Elconin, A. E. Karnoub, W. Bai, J. N. Rich, R. T. Abraham, C. J. Der, and C. M. Counter. 2002. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 16:2045–2057.
   PubMed Web of Science ®Google Scholar
• Hannon, G. J., and D. Beach. 1994. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257–261.
   PubMed Web of Science ®Google Scholar
• Harbour, J. W., R. X. Luo, A. Dei Santi, A. A. Postigo, and D. C. Dean. 1999. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98:859–869.
   PubMed Web of Science ®Google Scholar
• Hu, P. P., M. B. Datto, and X. F. Wang. 1998. Molecular mechanisms of transforming growth factor-β signaling. Endocr. Rev. 19:349–363.
   PubMed Web of Science ®Google Scholar
• Iavarone, A., and J. Massague. 1997. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387:417–422.
   PubMedGoogle Scholar
• Ishida, N., M. Kitagawa, S. Hatakeyama, and K. Nakayama. 2000. Phosphorylation at serine 10, a major phosphorylation site of p27Kip1, increases its protein stability. J. Biol. Chem. 275:25146–25154.
   PubMed Web of Science ®Google Scholar
• Janda, E., K. Lehmann, I. Killisch, M. Jechlinger, M. Herzig, J. Downward, H. Beug, and S. Grunert. 2002. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156:299–313.
   PubMed Web of Science ®Google Scholar
• Jiang, Y., R. C. Zhao, and C. M. Verfaillie. 2000. Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34+ cell proliferation: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27Kip1, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity. Proc. Natl. Acad. Sci. USA 97:10538–10543.
   PubMed Web of Science ®Google Scholar
• Knaus, P. I., D. Lindemann, J. F. DeCoteau, R. Perlman, H. Yankelev, M. Hille, M. E. Kadin, and H. F. Lodish. 1996. A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol. Cell. Biol. 16:3480–3489.
   PubMedGoogle Scholar
• Kretzschmar, M., J. Doody, I. Timokhina, and J. Massague. 1999. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev. 13:804–816.
   PubMed Web of Science ®Google Scholar
• Lehmann, K., E. Janda, C. E. Pierreux, M. Rytomaa, A. Schulze, M. McMahon, C. S. Hill, H. Beug, and J. Downward. 2000. Raf induces TGFβ production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 14:2610–2622.
   PubMed Web of Science ®Google Scholar
• Liang, J., J. Zubovitz, T. Petrocelli, R. Kotchetkov, M. K. Connor, K. Han, J. H. Lee, S. Ciarallo, C. Catzavelos, R. Beniston, E. Franssen, and J. M. Slingerland. 2002. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8:1153–1160.
   PubMed Web of Science ®Google Scholar
• Lim, K.-H., A. T. Baines, J. J. Fiordalisi, M. Shipitsin, L. A. Feig, A. D. Cox, C. J. Der, and C. M. Counter. 2005. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 7:533–545.
   PubMed Web of Science ®Google Scholar
• Liu, X., Y. Sun, M. Ehrlich, T. Lu, Y. Kloog, R. A. Weinberg, H. F. Lodish, and Y. I. Henis. 2000. Disruption of TGF-β growth inhibition by oncogenic Ras is linked to p27Kip1 mislocalization. Oncogene 19:5926–5935.
   PubMed Web of Science ®Google Scholar
• Lo, R. S., D. Wotton, and J. Massague. 2001. Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. EMBO J. 20:128–136.
   PubMed Web of Science ®Google Scholar
• Malek, N. P., H. Sundberg, S. McGrew, K. Nakayama, T. R. Kyriakides, and J. M. Roberts. 2001. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature 413:323–327.
   PubMedGoogle Scholar
• Markowitz, S., J. Wang, L. Myeroff, R. Parsons, L. Sun, J. Lutterbaugh, R. S. Fan, E. Zborowska, K. W. Kinzler, B. Vogelstein, M. Brattain, and J. K. V. Willson. 1995. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336–1338.
   PubMed Web of Science ®Google Scholar
• Miyazono, K. 1997. TGF-β receptors and signal transduction. Int. J. Hematol. 65:97–104.
   PubMedGoogle Scholar
• Miyazono, K., P. ten Dijke, and C. H. Heldin. 2000. TGF-β signaling by Smad proteins. Adv. Immunol. 75:115–157.
   PubMed Web of Science ®Google Scholar
• Moeller, S. J., E. D. Head, and R. J. Sheaff. 2003. p27Kip1 inhibition of GRB2-SOS formation can regulate Ras activation. Mol. Cell. Biol. 23:3735–3752.
   PubMed Web of Science ®Google Scholar
• Montagnoli, A., F. Fiore, E. Eytan, A. C. Carrano, G. F. Draetta, A. Hershko, and M. Pagano. 1999. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13:1181–1189.
   PubMed Web of Science ®Google Scholar
• Muller, D., C. Bouchard, B. Rudolph, P. Steiner, I. Stuckmann, R. Saffrich, W. Ansorge, W. Huttner, and M. Eilers. 1997. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene 15:2561–2576.
   PubMed Web of Science ®Google Scholar
• Muller, D., K. Thieke, A. Burgin, A. Dickmanns, and M. Eilers. 2000. Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60. EMBO J. 19:2168–2180.
   PubMed Web of Science ®Google Scholar
• Niv, H., O. Gutman, Y. I. Henis, and Y. Kloog. 1999. Membrane interactions of a constitutively active GFP-Ki-Ras 4B and their role in signaling: evidence from lateral mobility studies. J. Biol. Chem. 274:1606–1613.
   PubMed Web of Science ®Google Scholar
• Oft, M., R. J. Akhurst, and A. Balmain. 2002. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat. Cell Biol. 4:487–494.
   PubMed Web of Science ®Google Scholar
• Oft, M., J. Peli, C. Rudaz, H. Schwarz, H. Beug, and E. Reichmann. 1996. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10:2462–2477.
   PubMed Web of Science ®Google Scholar
• Orend, G., T. Hunter, and E. Ruoslahti. 1998. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene 16:2575–2583.
   PubMedGoogle Scholar
• Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682–685.
   PubMed Web of Science ®Google Scholar
• Park, K., S. J. Kim, Y. J. Bang, J. G. Park, N. K. Kim, A. B. Roberts, and M. B. Sporn. 1994. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA 91:8772–8776.
   PubMed Web of Science ®Google Scholar
• Paz, A., R. Haklai, G. Elad-Sfadia, E. Ballan, and Y. Kloog. 2001. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 20:7486–7493.
   PubMed Web of Science ®Google Scholar
• Pietenpol, J. A., J. T. Holt, R. W. Stein, and H. L. Moses. 1990. Transforming growth factor β1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci. USA 87:3758–3762.
   PubMed Web of Science ®Google Scholar
• Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9–22.
   PubMed Web of Science ®Google Scholar
• Pruitt, K., R. G. Pestell, and C. J. Der. 2000. Ras inactivation of the Rb pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells. J. Biol. Chem. 275:40916–40924.
   PubMedGoogle Scholar
• Reynisdottir, I., and J. Massague. 1997. The subcellular locations of p15Ink4b and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11:492–503.
   PubMed Web of Science ®Google Scholar
• Roberts, A. B., and M. B. Sporn. 1993. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8:1–9.
   PubMed Web of Science ®Google Scholar
• Rodier, G., A. Montagnoli, L. Di Marcotullio, P. Coulombe, G. F. Draetta, M. Pagano, and S. Meloche. 2001. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 20:6672–6682.
   PubMed Web of Science ®Google Scholar
• Saha, D., P. K. Datta, and R. D. Beauchamp. 2001. Oncogenic ras represses transforming growth factor-β/Smad signaling by degrading tumor suppressor Smad4. J. Biol. Chem. 276:29531–29537.
   PubMed Web of Science ®Google Scholar
• Schwarz, L. C., M. C. Gingras, G. Goldberg, A. H. Greenberg, and J. A. Wright. 1988. Loss of growth factor dependence and conversion of transforming growth factor-β1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts. Cancer Res. 48:6999–7003.
   PubMedGoogle Scholar
• Sekimoto, T., M. Fukumoto, and Y. Yoneda. 2004. 14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27Kip1. EMBO J. 23:1934–1942.
   PubMedGoogle Scholar
• Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512.
   PubMed Web of Science ®Google Scholar
• Shi, Y., and J. Massague. 2003. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685–700.
   PubMed Web of Science ®Google Scholar
• Shields, J. M., K. Pruitt, A. McFall, A. Shaub, and C. J. Der. 2000. Understanding ras: ‘it ain't over ′til it's over’. Trends Cell Biol. 10:147–154.
   PubMed Web of Science ®Google Scholar
• Shin, I., F. M. Yakes, F. Rojo, N. Y. Shin, A. V. Bakin, J. Baselga, and C. L. Arteaga. 2002. PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization. Nat. Med. 8:1145–1152.
   PubMed Web of Science ®Google Scholar
• Shirane, M., Y. Harumiya, N. Ishida, A. Hirai, C. Miyamoto, S. Hatakeyama, K. Nakayama, and M. Kitagawa. 1999. Down-regulation of p27Kip1 by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J. Biol. Chem. 274:13886–13893.
   PubMedGoogle Scholar
• Sugiyama, Y., K. Tomoda, T. Tanaka, Y. Arata, N. Yoneda-Kato, and J. Kato. 2001. Direct binding of the signal-transducing adaptor Grb2 facilitates down-regulation of the cyclin-dependent kinase inhibitor p27Kip1. J. Biol. Chem. 276:12084–12090.
   PubMed Web of Science ®Google Scholar
• Tian, X., G. Rusanescu, W. Hou, B. Schaffhausen, and L. A. Feig. 2002. PDK1 mediates growth factor-induced Ral-GEF activation by a kinase-independent mechanism. EMBO J. 21:1327–1338.
   PubMed Web of Science ®Google Scholar
• Tomoda, K., Y. Kubota, Y. Arata, S. Mori, M. Maeda, T. Tanaka, M. Yoshida, N. Yoneda-Kato, and J. Y. Kato. 2002. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J. Biol. Chem. 277:2302–2310.
   PubMed Web of Science ®Google Scholar
• Tomoda, K., Y. Kubota, and J. Kato. 1999. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398:160–165.
   PubMed Web of Science ®Google Scholar
• Tsubari, M., J. Taipale, E. Tiihonen, J. Keski Oja, and M. Laiho. 1999. Hepatocyte growth factor releases mink epithelial cells from transforming growth factor β1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity. Mol. Cell. Biol. 19:3654–3663.
   PubMedGoogle Scholar
• Viglietto, G., M. L. Motti, P. Bruni, R. M. Melillo, A. D'Alessio, D. Califano, F. Vinci, G. Chiappetta, P. Tsichlis, A. Bellacosa, A. Fusco, and M. Santoro. 2002. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 8:1136–1144.
   PubMed Web of Science ®Google Scholar
• Vlach, J., S. Hennecke, and B. Amati. 1997. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16:5334–5344.
   PubMed Web of Science ®Google Scholar
• Wolfman, J. C., T. Palmby, C. J. Der, and A. Wolfman. 2002. Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38. Mol. Cell. Biol. 22:1589–1606.
   PubMedGoogle Scholar
• Wolthuis, R. M., N. D. de Ruiter, R. H. Cool, and J. L. Bos. 1997. Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J. 16:6748–6761.
   PubMed Web of Science ®Google Scholar
• Yamazaki, Y., Y. Kaziro, and H. Koide. 2001. Ral promotes anchorage-independent growth of a human fibrosarcoma, HT1080. Biochem. Biophys. Res. Commun. 280:868–873.
   PubMedGoogle Scholar